EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors

Clinical trial NCT03638167 · COMPLETED

Trial details

NCT number: NCT03638167
Sponsor: Seattle Children's Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Tumor, Pediatric Glioma Ependymoma Medulloblastoma Germ Cell Tumor Atypical Teratoid/Rhabdoid Tumor Primitive Neuroectodermal Tumor Choroid Plexus Carcinoma Pineoblastoma

Start date: 2019-03-19
Primary completion: 2023-12-22
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.